SARA ABI: Open Payments
NPI 1093130403 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,508 in 148 payments from 15 companies in 2025. Trend: 2023 $1,705 · 2024 $1,889 · 2025 $2,508
Food & beverage: $2,508
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 25 | $513 |
| Alkermes, Inc. | 26 | $420 |
| Otsuka America Pharmaceutical, Inc. | 12 | $277 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $276 |
| ABBVIE INC. | 23 | $212 |
| Janssen Pharmaceuticals, Inc | 12 | $167 |
| E.R. Squibb & Sons, L.L.C. | 11 | $143 |
| Neurocrine BioSciences, Inc. | 7 | $120 |
| Lundbeck LLC | 4 | $89 |
| Supernus Pharmaceuticals, Inc. | 3 | $75 |
Products named: HETLIOZ, ARISTADA, REXULTI, CAPLYTA, VRAYLAR, COBENFY, INGREZZA, SPRAVATO.
Industry payments across OH — which companies pay providers there.
